This list is non-exhaustive
The National Institute for Health and Care Excellence (NICE) guideline [NG78]
This guideline covers diagnosis and management of cystic fibrosis. It specifies how to monitor the condition and manage the symptoms to improve quality of life.This summary article of the guideline NG78 has been reviewed and approved by NICE, and is available in different languages:
Brazilian (Portuguese) | English | German | Spanish | Polish
These guidelines from Grupo Brasileiro de Estudos de Fibrose Cística aggregate key scientific evidence to guide the management of patients across Brazil.
Chronic medications for maintenance of lung health
Systematic review of guidelines by the Pulmonary Clinical Practice Guidelines Committee on chronic medications for the maintenance of lung health.
Consensus conference report
Systematic review of guidelines by the Pulmonary Clinical Practice Guidelines Committee on chronic medications for the maintenance of lung health.
Use of cystic fibrosis transmembrane conductance regulator modulator therapy in patients with cystic fibrosis
Cystic Fibrosis Foundation clinical practice guidelines endorsed by the American Thoracic Society.
You are Leaving Medically
By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.
You are Leaving the Global Medically Site
By following this link, you are being redirected to another Roche page.